Wingspan One Year Vascular Imaging Events and Neurologic Outcomes

Completed

Conditions studied: Intracranial Atherosclerotic Disease (ICAD)

In brief

The purpose of the study is to determine the one-year post stenting outcomes in patients who were treated with the Wingspan stent on-label in the WEAVE trial. This includes both the assessment of any stroke, hemorrhage, or death, as well as assessment of delayed imaging results to determine the re-stenosis rate of the stents in these patients.

Key facts

Study ID

NCT04221984

Run by

Cedars-Sinai Medical Center

People needed

129

Starts

2019-11-12

Expected to finish

2020-05-19

Last updated by the study team

2021-07-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Inclusion criteria for this study are the 152 patients stented in the WEAVE trial on-label.
• The patients had the following inclusion criteria:
• Age 18-80
• Intracranial artery stenosis greater or equal to 70% stenosis
• Target artery 2 mm or larger
• Presented with stroke while on medical therapy for stroke prevention
• Prior stroke in the target territory
• Modified Rankin Score of 3 or better (neurologic function)
• Treated greater than 7 days after their last stroke
• Treated with the Wingspan stent by an approved trial NeuroInterventionalist

You may not qualify if…

• Patients treated outside of the trial or who did not meet the entry criteria.
• Patients that had stent treatment for arterial dissection
• Patients that had extra-cranial stenosis
• Patients outside the age range of the study
• Patients treated less than 8 days from their stroke.

Where it is running

• Cedars Sinai Medical Center — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.